|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 2907 |
FusionGeneSummary for ASAP1_SAMD12 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ASAP1_SAMD12 | Fusion gene ID: 2907 | Hgene | Tgene | Gene symbol | ASAP1 | SAMD12 | Gene ID | 50807 | 401474 |
| Gene name | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | sterile alpha motif domain containing 12 | |
| Synonyms | AMAP1|CENTB4|DDEF1|PAG2|PAP|ZG14P | - | |
| Cytomap | 8q24.21-q24.22 | 8q24.11-q24.12 | |
| Type of gene | protein-coding | protein-coding | |
| Description | arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1130 kDa phosphatidylinositol 4,5-biphosphate-dependent ARF1 GTPase-activating protein130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating proteinADP-ribosyl | sterile alpha motif domain-containing protein 12SAM domain-containing protein 12 | |
| Modification date | 20180523 | 20180521 | |
| UniProtAcc | Q9ULH1 | Q8N8I0 | |
| Ensembl transtripts involved in fusion gene | ENST00000357668, ENST00000518721, ENST00000520625, | ENST00000409003, ENST00000314727, ENST00000527515, | |
| Fusion gene scores | * DoF score | 20 X 11 X 10=2200 | 7 X 6 X 9=378 |
| # samples | 22 | 13 | |
| ** MAII score | log2(22/2200*10)=-3.32192809488736 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(13/378*10)=-1.53987461119262 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: ASAP1 [Title/Abstract] AND SAMD12 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | LUAD | TCGA-35-4122-01A | ASAP1 | chr8 | 131370263 | - | SAMD12 | chr8 | 119209971 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000357668 | ENST00000409003 | ASAP1 | chr8 | 131370263 | - | SAMD12 | chr8 | 119209971 | - |
| 5CDS-intron | ENST00000357668 | ENST00000314727 | ASAP1 | chr8 | 131370263 | - | SAMD12 | chr8 | 119209971 | - |
| 5CDS-intron | ENST00000357668 | ENST00000527515 | ASAP1 | chr8 | 131370263 | - | SAMD12 | chr8 | 119209971 | - |
| Frame-shift | ENST00000518721 | ENST00000409003 | ASAP1 | chr8 | 131370263 | - | SAMD12 | chr8 | 119209971 | - |
| 5CDS-intron | ENST00000518721 | ENST00000314727 | ASAP1 | chr8 | 131370263 | - | SAMD12 | chr8 | 119209971 | - |
| 5CDS-intron | ENST00000518721 | ENST00000527515 | ASAP1 | chr8 | 131370263 | - | SAMD12 | chr8 | 119209971 | - |
| intron-3CDS | ENST00000520625 | ENST00000409003 | ASAP1 | chr8 | 131370263 | - | SAMD12 | chr8 | 119209971 | - |
| intron-intron | ENST00000520625 | ENST00000314727 | ASAP1 | chr8 | 131370263 | - | SAMD12 | chr8 | 119209971 | - |
| intron-intron | ENST00000520625 | ENST00000527515 | ASAP1 | chr8 | 131370263 | - | SAMD12 | chr8 | 119209971 | - |
Top |
FusionProtFeatures for ASAP1_SAMD12 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ASAP1 | SAMD12 |
| Possesses phosphatidylinositol 4,5-bisphosphate-dependent GTPase-activating protein activity for ARF1 (ADPribosylation factor 1) and ARF5 and a lesser activity towardsARF6. May coordinate membrane trafficking with cell growth oractin cytoskeleton remodeling by binding to both SRC and PIP2. Mayfunction as a signal transduction protein involved in thedifferentiation of fibroblasts into adipocytes and possibly othercell types (By similarity). Plays a role in ciliogenesis.{ECO:0000250, ECO:0000269|PubMed:20393563}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | >SAMD12 | chr8:131370263 | chr8:119209971 | ENST00000314727 | - | 0 | 4 | 77_143 | -46 | 202 | Domain | SAM |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | >ASAP1 | chr8:131370263 | chr8:119209971 | ENST00000357668 | - | 2 | 29 | 783_993 | 62 | 1130 | Compositional bias | Note=Pro-rich |
| Hgene | >ASAP1 | chr8:131370263 | chr8:119209971 | ENST00000518721 | - | 3 | 30 | 783_993 | 62 | 1130 | Compositional bias | Note=Pro-rich |
| Hgene | >ASAP1 | chr8:131370263 | chr8:119209971 | ENST00000357668 | - | 2 | 29 | 1067_1129 | 62 | 1130 | Domain | SH3 |
| Hgene | >ASAP1 | chr8:131370263 | chr8:119209971 | ENST00000357668 | - | 2 | 29 | 324_416 | 62 | 1130 | Domain | PH |
| Hgene | >ASAP1 | chr8:131370263 | chr8:119209971 | ENST00000357668 | - | 2 | 29 | 439_560 | 62 | 1130 | Domain | Arf-GAP |
| Hgene | >ASAP1 | chr8:131370263 | chr8:119209971 | ENST00000518721 | - | 3 | 30 | 1067_1129 | 62 | 1130 | Domain | SH3 |
| Hgene | >ASAP1 | chr8:131370263 | chr8:119209971 | ENST00000518721 | - | 3 | 30 | 324_416 | 62 | 1130 | Domain | PH |
| Hgene | >ASAP1 | chr8:131370263 | chr8:119209971 | ENST00000518721 | - | 3 | 30 | 439_560 | 62 | 1130 | Domain | Arf-GAP |
| Hgene | >ASAP1 | chr8:131370263 | chr8:119209971 | ENST00000357668 | - | 2 | 29 | 600_632 | 62 | 1130 | Repeat | Note=ANK 1 |
| Hgene | >ASAP1 | chr8:131370263 | chr8:119209971 | ENST00000357668 | - | 2 | 29 | 636_665 | 62 | 1130 | Repeat | Note=ANK 2 |
| Hgene | >ASAP1 | chr8:131370263 | chr8:119209971 | ENST00000518721 | - | 3 | 30 | 600_632 | 62 | 1130 | Repeat | Note=ANK 1 |
| Hgene | >ASAP1 | chr8:131370263 | chr8:119209971 | ENST00000518721 | - | 3 | 30 | 636_665 | 62 | 1130 | Repeat | Note=ANK 2 |
| Hgene | >ASAP1 | chr8:131370263 | chr8:119209971 | ENST00000357668 | - | 2 | 29 | 454_477 | 62 | 1130 | Zinc finger | C4-type |
| Hgene | >ASAP1 | chr8:131370263 | chr8:119209971 | ENST00000518721 | - | 3 | 30 | 454_477 | 62 | 1130 | Zinc finger | C4-type |
Top |
FusionGeneSequence for ASAP1_SAMD12 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| >In-frame_ASAP1_ENST00000357668_chr8_131370263_-_SAMD12_ENST00000409003_chr8_119209971_-_69aa |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| >In-frame_ASAP1_ENST00000357668_chr8_131370263_-_SAMD12_ENST00000409003_chr8_119209971_-_209nt ATGAGATCTTCAGCCTCCAGGCTCTCCAGTTTTTCGTCGAGAGATTCACTATGGAATCGGATGCCGGACCAGATCTCTGTCTCGGAGTTC ATCGCCGAGACCACCGAGGACTACAACTCGCCCACCACGTCCAGCTTCACCACGCGGCTGCACAACTGCAGGAACACCGTCACGCTGCTG |
| * Fusion transcript sequences (Full-length transcript). |
| >In-frame_ASAP1_ENST00000357668_chr8_131370263_-_SAMD12_ENST00000409003_chr8_119209971_-_8488nt GGTCGTTTTCTGATGTGACGGCTGAGACATGAGATCTTCAGCCTCCAGGCTCTCCAGTTTTTCGTCGAGAGATTCACTATGGAATCGGAT GCCGGACCAGATCTCTGTCTCGGAGTTCATCGCCGAGACCACCGAGGACTACAACTCGCCCACCACGTCCAGCTTCACCACGCGGCTGCA CAACTGCAGGAACACCGTCACGCTGCTGGAGGAGCATCATCTGAGGGTTCTCCATAAACACGGTTAGCCTTCCAAGCTGCTGTCCTGCCA GTTGATATGAACATGGCCTGTTCCTCACAGAAAGACTAACCCATGGCACTGCCAGAAGATATCCTTGGATCGTGGACAGATTAACTGGAT TAACTGAAAAAAGCACCCATTCAGTCAATATTATGGGTTTTGGAAAAATCTTGCTTTGCTGTGGATTTAAAATGAGGTGCATAATATAAT GCCAACTCATTCCAAGTGGTCATTGGCAGACCATTAGCTGGAAAATTGCTTCCAGTTTTCATCACTGTGCATAACTCAAGTTCCCTTTGG GGAGCTGTCTGTGCCCTTCACTAGAAGTCCTGTTTTAGCATGGCAACTACTGGATTATTTTATTATGTGTGCAGATGGCATGATGTTTTA GAAAAAAAAAATTACAGCAATTCTGCAATCTCAGTGGAAGTGTTCACAATATTATGCCCTGGTAGGAATGTAAACACGTCTCGATTATGT TAGTTATGATGTCTAAAGGTATACTGTCCAACTCTTAAGCACTTTATATGAGAACACTACACCAAGATGAATCAGCACATTCAGCACATG TGAGAAATCAAGTATTTTCTTTTTATTTTTATAAATCTTAGTGGTTTTTTTTTTTCCGGCTCAGACTGTCCAAGACAAACTCCACTACTC GCATATCCCCAGTTGTTTGTGGTAGGTTGATGTAAATATGGCCACAATACTGTTAGACTTCACCTCCAGATACTTTATTGAACAACTGGT TTACTTCTAGCACCAAAGGGAAGAAGAAGGGGGTCCAGTGATGGTGATATCTTAGCTTGCTTCTTTGTTCACAGGCACTATTGACCACAT GAACATACAGGTACTCAAATACAGGAGGCTTCTATTTGGCTCCTCCAAGGGAGGAGTTCCTCCAAGGGAAAAAAGGGGATGGTATTCTTT TAATCAAAGACCATGGTGGATGGATGGTAAGGGCAACAGAATGCAATTCTTTTGTGTGGTCTGACGTTAACACTTCGGAAAAAATTCTAA GTCAAGTTGAAATCGCCATTCTCTCAAGAGAGAAACATCAAGAGAGAAACATCAAGTGACCCCACTATGTGCCTAGAGAAGGAAAAGGGT CAAGTCCTATACTAGGTTCCTTACTTAGGGTAGAACCTACTAGTCCCTTGTTAATCCTTTCTGGGATTATACCTGTGACTAATTTTTTTT TTTTTAACTATGTCTTACGACAAAGCACAGTCCTGGGAAACCAGTCAACTTAATTATTGCTTGTCTTTGAGCATTAGAGACATGTTCATA TTGACTTGCTACATAACACTGTAGCATGTTTTTTCCTGAAAATATCAAGTTGGTTGAATGGAAAGCTCAGCAAAGTATGTTCTGTGTGCC CACTGTCCCAGCCTGGGACTGACGGGCATCAGAGGCTTTGCTTTAAAATATGGGTAACCAGTTCTGGAAGACTTCCAACGCAAGCAAGCT TGGTGTTTTAGGGTGTCTCCAGATACATAAGCATTGTCTGCCTCCGCTCAGGGTCTCAGGAAATACACAGCCCATTGGAAACCACCCACG CCTGAGATTTGGAAACCTGACGGAAAGGGAGGAAGGTCCAAATGAGTCAGCAGCAGGATGACTCACCACAAGCCTGGCAGGCTGCAGAGC CAGAGAAGGGGGCTTCCAACAAGGAACTCAGAGAAGTTGCAGTCACCACCAAGATCTGGCCCTTCGGCAGGTCAGCACCAGGACTGCCAG GCCCTCTGCAGACCGTAATTCTCTTCACATCTATAATTAGGAGGCCAAACTCCAGCTGCCAACACCCTTGGACACAATATTCCAGTCTCC ACTGCCCATCTCATGTGGTTCAGTTCTAATAGCAGGTCTTCTTCTTCCTTTCATTCCTTCCTTTATTCAGCAAGCATTTGTTGAGCATCT ACTATGTGCCAAGCATTGTGCTTGGGCAACAACAGTCCACAAAGCAGACTCCCCACCTGCCCTTATGAAACTGTATCTCCTCCTCCCCAA CATTATCACCACCCCACCATTTCCACAATGAAAACTGAATTCAGACAGCATTCTCCATTCTGCCAGAGTAACCTAGGAAGAAGAACATGG CAGCAGACGGATCCTCAGGGAGGAGGCAGCAGAGTGACAGATGGTAAACTGCATCAGGCCACATATTTGCACCTTTCAGATACAGCCAAC TCTTCCAGGGCCTAGACTGAGCTGGTTGGAGCTCCCCAAAGCAGCATTCAGTTGCTTTTCCTTGATATCCACCCTGGCTACCTATATTCC CTTTCTTTATATAGGCACAACCATTCACCACTACGCTGGATTATCTAACACTCCAATTCTATAACTCATCCAGGGGACACACAGTTGAGT CTGATGAAGCCTAAGAACTGCCAGGTGCTGAGATATTGTAACTGGGAATTAAGATTTAGCCAAGGACATTGTGAGACTACTGCTGACTCT CTTGGAAAACTGGACATGCTTTGTAGTGCAAATGTTCACTAAATGATGGTGGTTCATTGTTACTTACTTTGGCCTTTGCAAAATATTCTG AACAATTCAATAAGTAGAGTTTCCTAGTTTGTTTGTTTTTTTAAGTCAAAGGAACGCTGTGAAATTATTGAAAGATGATGGGTGAAGAGG GACCTAGGAGAAGGCAAAATGAAGACCATTAAAGAGCCCCATTGAAGACTGTATCTCTAAAAATGCCTTAATGCCTGGCACATATTCCAT ATTTGCATATGAACTACTATTCTTTTCCAAACTGTCAACTTCTGTTTGAAATCATTGTGGGGGATAGTTTGGAAATATGGTGGCATAAAA TCCAAGCAGTCAAGAGCTAAACCAGCAAAAAAGAGGAATGACTTCATTCACAGGCTTTGGCTTCTTTATTATGTGGTGGTCCTCTGTGAT CTCCCATGGTTAACTTCAACTGTGCTGTACTTTCTTCCCAAGATGCATGTACGGAATGTTACCTCCTAGAAATCCAGAAATAGTTGTGGT GAGTTTTGTTTGATAGGAAGCAAGAGGTGGGGAAGTAAAGGATACATATTTTTATGTCTAAGGACTGTAAACTGTTGATGCTTGACTTTT CCTTTTACCTACACCTGTGCTACACCTTTATTAAAAGGCTGACACCCAGACTTGTGCAGGAAAGGCACTCTTGGGAATGAACAGAAATGA ATAATTATGAGACTTTCCATGGTGCCAAGGGGATTCGCTTATTTCCACTCCAGAACTGAATATGCAGAGCATTGCCAGTCCTGCTAGTGT GAAAAGCAAATTACTTCAATAGTTTGAGACGTACCTAGGGGAAGAGAGATCCTATCAACTTTCTTTGCGGGTAGTGGCGTACCTTCAAAT CCTTGCTCAGGCTCTGTGAGGTGTGCACCCGCAGATTTCACTTCTACCTCCGGAATCCTGGCAAACAAGCCAGGAATCTCTCCAGAGTCA CTTCGCAGTTGCTCAGAAAGAGGCTAACGGTCCTTAGTCCTGAGGAAATTCTGCCATTTTTAACATTCAAGGAGAAAAGGCGTATCAGCT GTACGTGAGAATATCAACTAAGGATAAAAACCTCTAATGGATCCCCCTTGTTACTTGCAAATGCTTTCTTTGTCTGCAAATGTCACATAA TTGATTTTGCATAGGAACAACAAAAGTCTCAAGGAATTGAAGTTTTTAATACCCCCCTTAGCACTTTACTTTCACCAAAACCTCCTCTTT CTAGTACATGAGCAGTTTTGTTCTTTGTGATGTTTTCCTCTACATTCTTTAGAATAATTTTGTTACTTGACAACTAGACTTGTCAATCGT CTTAGACTCTTTTGAAAAATCTAATCTTTGAAAATGACACAAATTCCTTTATTGCTTTAAGGCTGTTTTCATTCACCCCTCCCACAGCCC CCTCCACTGCACTTTTTTGTTTTTTGCGGGGATTTTTTTCTTTCATCTCTCTTCTTTTAACATGATGCTGTGGGTAGTTTTCAAGAATTC TATAAAGAACTCAACAAAAAGTGTATTTGTTACCTTTTTCCCCAGTCCTAATATTTCTTCTTAAGCTTGATCTTGGTGAAAATTTGTTGC CCAAAAAGCAGTGAGGTAGGGATTAATAACGCTGACCAGTCATCTGGAAGATTAATTAATCCCAGTGCAGCCCTGAGATCAGGAAGGAGG ACAGGCCAGGAGATGTTTCTACTCCAGGCACCACTAAGGACTCTATTTCAAAGGCAGATCCTGCTCCTTAGTCTTTTTAGATCTGAATCT AATCCTGAATCCAGAAAATTATCCTATGAATTCTGGTTTATCAACGCACATGATTCCTGGCACCATTGCATAGCTTCAAGGTAAAAGAGA GCCTTGTTTCCATTATTTTGCTATGGTGGCTTTTGGGAAGACAGAGAGCATTCTTTTGAAAGCGGGAAACTTAAGGAAAAGTTGGCCAAG TACACAGGAAAGTTCTACCACACCTTAATATAAAGAACAAAATAGATGCTTCTCATTTGGGGAAAGTAGCTAAAAGGACAGTAACAGTAC TGATGGCCTTCTGTCCATCACCTTAGCTCCACAGGGAAAATTCTGGGTGAGAGCAAGCACTGTTTCTAAAATCTAAATTTTTTCAGGTGA AATTTACCAGCAACAAATGTAAAAGGGAACTGCCATCAGGCATAGGGCTAGTTTTATACTTCCTGCCTAACGGCAAAATGACTGAGACAT GACTTCCATGGAACAGCAGAAAATGGATGCCAAAGATATCATAAAACTGAAGTTCAATTTGCCACGTAAGGCTATTTAAAAACCCTGATG CACTCCAAGCATTCTTCCTTCAGAGCTTTCCTCCTACAATTATATCAAGCACAAGAAGGCACCAACAGCATATACTTAATGTAATGTAAA AGTAAACATATGACTTGTGTTGAATTACCATTGGCTGGTTGACATAATAAGTGTCATAGATATTTAGACATTATTTCTGATCATACAAAA TTATTTTCATAATTTCATATTCTTTTCAATTTTCATAAATTCTTTTCAATTTTCATAAATTGGAGCCAATGGTTTGGGAGGTTTTTTGTT TGTTTGTTTGTTTGGTTGGTTGGTTATTTGTTGCGTTGTTGTTTTCCAAACCTCAGATATTTTGAGAAGCCTTAGAAAGGCTCTTAAGCC CAGGCCTTTTTGCCTCATGTGCAGAGTATTAATAACAGCCCTACTGATGTGAACCTCAAGGAAGGAGGCTATTAAATTAATCCATCACTG GAGATACTAATACCTCAAACAATTAAAACACTGAAGACTCTGCTGGTTGCCTTCCACATTGTTTATAACCTTTTTAAATTCAGTCATTTG GATCAAGAGAAATAAATGGTTGGTTTCATATGGCTTTTGCCACATTAGCACAGACACATCTACCAAATGTAGAAGTCCAGACTGAGTGGA TGCATGAGAGCAAACAGATCTGTAATATGATTGCATTTAATCACCGCCACCGCCCAAATTCTGTAAAAATATATTCAAATATGTAATGCT AAAAAAAATGCAAAACAGGAGACTCTTACTAGATCATGCTTTCACTTAGGGTAGGATAACTGATCTTGAAGATAACTTCATAGAAAAATT TGCTGGCTGAAATGCCCCAGGCACCTCAGGGTTGGTCCTGTCCTATTCCACAAACTGATCATGGTCTTCTCCCATCTTCTCAGAGGAGTT AGCCTTGCCTCTAAAATAGCAAAAATGCCATGAAATTATCTTTCTAACCTCTATAGAGACTTCTTATCCAAGTATAATTCCAAAAATATG ATTTGAGTTTGAGCATGCCTGTGGTCCTTGATTCTATGATCCCTAAATCAGTTCTACTTTTCTCACTCTCTCTCTCTCTCTCTCTCTCTC TCTCTCTCTCTCTCTATATATATATATATATATATATATATATATATATATATATATATATATATATATAATCTCCAGTATTTTTTTTCA ACCACAATTTAGTGCATTTAGCGTGTTAATGTTGGGAACTGCCTGCTGGCTCTATGTCTACTTTTGACAATGCTTATGTCCAGATACCAT ACAGTGCATTTGAGAGAGGACCAAGGTTATGTTTTCCCACATACCAGCTGCTGCAGAGGTTTCGAAGTGCCTGACCCAGTTCTTTTTCAC ATCAAAAAGGCCTTCGGTTGCAGATGGAAACCTTAAAGATGAATGTAGAGTGGGGTAGGAAATTCATGTTTGAATGCTGAAACCCTTGTC TTTTTTAGTTTTATTCAATTCCCACCTCAGATCACCAGAAAGGGAGGCCTCTTTGGTGGGTGTTGGCCCTCACTGGGGGTAAAAGGGGTT CTATTTGCTTAAACTCATGCTCGTAGGCAATTTTAGGGCTCTCTGGGGCTCTGAATGGTTTCTCCACCACCACCTTTCTTCCACCAATAG AAAGATGTTGTCCTTACAAGGCCATGTCTGAGAAGACCATGGTTTAACTAGTAAAAGAAGCTCACATTGCAGAGAGCTGAATAATACCAG GCTCTTGACTTTGTACTGTGTGTCACAGTCATGATTGGGACAGAAGGAACCAGTCTGCTGAAAAGTCAAGCCAGCACAAATATTTGGAAA CTAATTCCACTGAAACTCTTGTATCATTAAATCATACTATTGTAGTTTCAGTTAATGTAATTATTTAATATCAGGCACTAAATTAAATAG CTTTGCACAAAATTTTAGAAAAGATCAATCTTGTAACAAAATTTAATATTAACAGTAAAAAGCACCTGAGAAAAGAAAATATCGATCTGT TGTGGTTTATATACTTGAGTTATTCTTAGAACTTTGTGGAGATTGACACTGCTCTGATAAAAAGGAAGAAAATGTTTTGAATTCAAGAAT GCTAGACTAATAGAAATAGCCCAGTCTCTCTGGGCCACTGCTCTTCAGTATGGGGTGCTCTCTGTCCCTCCTTAGCAGATGGGGTTGTTT GGAGGCTAAAATGAGCTAAGGGAAGAAGCTATACTGTGCCTCCAATATCCCTTATGTGTAATTAGAGTGCCGATCTGGGCTGCAGGCTTT ATTCAATGATTCCTTTCCCTTACTTGAGGCTTTCTCTGTAGAGCTGTTATTTCTGAGCCTCCATTCTGGGATTTACAAAGGAAACAGAAT GATGAAGAAGTAACAATCAGCATTTTACACACACGCACACACACACACACACACACACTTTTTCTAATATATGAGGCTAGTCTGCAGAGT CCACAGCCCAGGTGTCCATTTATTTCCACTTCTTCACCTCCCAAAGATTTAGAGCTCCATGATCTACCAAGGTGAAGACTGCCAATCCCA GGTTGGAGAAGACCCGTCAGAGTGTGGAGGTGCCAAACTGAGAGGCACAGGAAGCAGACAGCCACATCAAACTTTTTTGATGAACTACTG CAAATTGGTGTTTGTTCTAGGAAAGAAAGAGGAAGAAAAATTACACAATGTGAATTGAACATAAGAGCAGTGCTCTTTACAGAGTATGAG AAGGGAGGATGGGGGAGAATCTGATTAAAAAAATGATTCATTCCTTCACAGACACTAACAAACATGGCTAAAAAGCACATGTCAGAACAC AGAAGCCTAGGTAGATGGTTGACATTTTTATAACTTCCTTAAGTGAGTAGTTAAACCAGCAGTCTTAATTCTGTTGGTCTTCCAAGAGTG TTTAATTACATAAGTATTACCTGTATTCATTTCCCACAACTGTTGGGTTTTTCTTTCTTTTTTTTTTTTTTTTTTTTTTTCCTCTGTGCA TCCTAGAAAAACTCCCAGGACTAGACTTAGGAGGAGGCAATCAAGTTATGTGGTAAAACAAGAGTGCCTTTTCTGTTGGATATCCACTTT AGTTTCCTGGCTTCCAGGGCATAAGATGTTTAGAAACTTTTTTTCTCTAAACATAAGAATTATTGTGTACCACAATTTTGAACCACCGAT TTCCATATCTTCAGCAGCTATCAACTTGCCAATTCCCTTTGGGTCTCCTTTGTATATTCTTATGTTTCCTTCTGTTTCCAGTTGTCCTCA AAAAGAGTTGAGGGGGGCATGACTCTTATAAAATGGATAAAAATGAAACTGTACAGATGTTTGCCTCCCTTGTATCTGTGAGCATGATCT CTATCAGGCTGGAAAATCTGCTTTATCATTTTGTATATTTGACTATTTTGTATTCAGCATTACTTGACTCCTTATGTGCATGGCAATGTA |
Top |
FusionGenePPI for ASAP1_SAMD12 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| ASAP1 | SRC, CRK, PXN, PACSIN1, PACSIN2, PACSIN3, TRIP10, FCHSD1, GRB2, ARF6, ELAVL1, SH3KBP1, CBL, CBLB, ARAP3, CTTN, PTK2, LRRK1, NCK2, NTRK1, RAB11FIP3, RAB11FIP1, RAB11FIP2, CDH1, PTPN12, ASAP3, TRIM25, ARF1 | SAMD12 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ASAP1_SAMD12 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ASAP1_SAMD12 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | ASAP1 | C0005695 | Bladder Neoplasm | 1 | CTD_human |
| Hgene | ASAP1 | C0041327 | Tuberculosis, Pulmonary | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|